The Implications of the Pandemic with Covid-19 in the Glycemic Control of People with Type 2 Diabetes

被引:0
|
作者
Gherbon, Adriana [1 ,2 ,3 ]
Frandes, Mirela [4 ]
Nicula-Neagu, Marioara [5 ]
Timar, Romulus [1 ,2 ,3 ]
Timar, Bogdan [1 ,2 ,3 ]
机构
[1] Victor Babes Univ Med & Pharm, Dept Internal Med Diabet Nutr Metab Dis & Syst Rhe, Timisoara, Romania
[2] Victor Babes Univ Med & Pharm, Ctr Mol Res Nephrol & Vasc Dis, Timisoara, Romania
[3] Pius Brinzeu Emergency Hosp, Dept Diabet Nutr & Metab Dis, Timisoara, Romania
[4] Victor Babes Univ Med & Pharm, Dept Funct Sci Biostat & Med Informat, 2 Eftimie Murgu Sq, Timisoara 300041, Romania
[5] Banats Univ Agr Sci & Vet Med King Michael I Roman, Timisoara, Romania
关键词
type; 2; diabetes; COVID-19; lockdown; diabetes management; body mass index; LOCKDOWN; IMPACT; METFORMIN;
D O I
10.2147/DMSO.S434990
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: The COVID-19 lockdown influenced the glycemic control and other metabolic parameters in people with type 1 and 2 diabetes mellitus.Objective: To study the effects of COVID-19 lockdown on glycemic control in people with type 2 diabetes mellitus (T2DM).Material and Methods: Our study group included 120 Romanian people with T2DM from both urban and rural areas. We employed a structured questionnaire with multiple-choice to collect data about DM management during lockdown, the interaction with their diabetologist, the access to treatment, and what other factors influenced their DM management during the lockdown.Results: We did not observe an increase of numbers of hyper or hypoglycemia during the restriction period in people with T2DM. The number of glycemic imbalances was higher in people treated with insulin than those with oral antidiabetics (OAD) (p=0.003, X2=8.91). Regarding the causes of imbalances, we did not obtain a significant difference during the restriction period, neither between patients following treatment with insulin nor with OAD. On the contrary, we observed that only 26.7% of people with T2DM managed to maintain their weight or lost weight vs 73.3% patients who gained several extra kg (p<0.001, X2=52.26).Conclusion: The findings of this study have demonstrated that in people with T2DM, the COVID-19 lockdown determines better glycemic control among patients treated with OAD compared to those treated with insulin therapy. Anxiety, stress, and emotions were the main reasons that led to the increase in glycemic values of these patients. Also, most patients have gained weight either due to lack of physical activity or due to stress.
引用
收藏
页码:4109 / 4118
页数:10
相关论文
共 50 条
  • [21] COVID-19 Pandemic and Pediatric Type 1 Diabetes: No Significant Change in Glycemic Control During The Pandemic Lockdown of 2020
    Nwosu, Benjamin Udoka
    Al-Halbouni, Layana
    Parajuli, Sadichchha
    Jasmin, Gabrielle
    Zitek-Morrison, Emily
    Barton, Bruce A.
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [22] The effect of COVID-19 lockdown on glycemic control in patients with type 2 diabetes mellitus
    Papazafiropoulou, A.
    Athanasakis, G.
    Georgopoulos, M.
    Pantzopoulou, E.
    Christofilidis, G.
    Antonopoulos, S.
    SCIENTIFIC CHRONICLES, 2021, 26 (01) : 140 - 146
  • [23] The effect of COVID-19 lockdown on glycemic control in patients with type 2 diabetes mellitus
    Papazafiropoulou, A.
    Athanasakis, G.
    Georgopoulos, M.
    Pantzopoulou, E.
    Christofilidis, G.
    Antonopoulos, S.
    SCIENTIFIC CHRONICLES, 2021, 26 (02) : 140 - 146
  • [24] Impact of COVID-19 Lockdown on Glycemic Control in Patients with Type 2 Diabetes Mellitus
    Dogan, Fatima Bahcaci
    Takir, Mumtaz
    Dogan, Ozgur
    Torun, Cundullah
    ISTANBUL MEDICAL JOURNAL, 2023, 24 (04): : 375 - 378
  • [25] Impact of COVID-19 lockdown on glycemic control in type 1 diabetes
    Duarte, Vitoria
    Mota, Barbara
    Ferreira, Sofia
    Costa, Carla
    Correia, Cintia Castro
    ARCHIVES DE PEDIATRIE, 2022, 29 (01): : 34 - 36
  • [26] THE EFFECTS OF THE COVID-19 PANDEMIC ON PEOPLE WITH TYPE 2 DIABETES USING ONE DROP
    Lavaysse, L. M.
    Hoy-Rosas, J.
    Lee, M.
    Imrisek, S. D.
    Goldner, D.
    Dachis, J.
    Sears, L. E.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A20 - A21
  • [27] Impact of the COVID-19 pandemic on glycaemic control in people living with diabetes
    Manning, Liam
    Siddique, Najia
    Tun, Tommy Kyaw
    McDermott, John H.
    Sreenan, Seamus
    IRISH JOURNAL OF MEDICAL SCIENCE, 2024, 193 : S145 - S145
  • [28] Sustained Improvement in Glycemic Control in Emerging Adults with Type 1 Diabetes 2 Years After the Start of the COVID-19 Pandemic
    Swaich, Harshpreet
    Advani, Andrew
    DIABETES THERAPY, 2023, 14 (01) : 153 - 165
  • [29] Sustained Improvement in Glycemic Control in Emerging Adults with Type 1 Diabetes 2 Years After the Start of the COVID-19 Pandemic
    Harshpreet Swaich
    Andrew Advani
    Diabetes Therapy, 2023, 14 : 153 - 165
  • [30] IMPACT OF TELEHEALTH USE DURING THE COVID-19 PANDEMIC ON GLYCEMIC CONTROL AND OTHER BIOMARKERS AMONG TYPE 2 DIABETES PATIENTS
    Shao, Y.
    Shi, L.
    Nauman, E.
    Price-Haywood, E.
    Stoecker, C.
    VALUE IN HEALTH, 2022, 25 (07) : S472 - S472